Eris Lifesciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences has informed the exchanges that its trading window for insiders will be closed from October 01, 2025, until 48 hours after the company declares its Unaudited Financial Results for the quarter and half-year ending September 30, 2025. During this period, designated persons (including employees, directors, and their immediate relatives) are prohibited from trading in the company's shares. This is a routine SEBI-mandated compliance filing under the Insider Trading Regulations, 2015, ahead of the upcoming Q2/Half-Year results announcement.
This is a standard regulatory filing and does not directly affect shareholders or the stock price. However, it signals that the company's Q2 and Half-Year FY26 results are likely to be announced in late October or early November 2025, which investors should watch for as a potential near-term catalyst.